
Insmed (INSM) had the best year in 2000 by a US stock with a market cap of $1B+ in 2000, returning 45,007.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Insmed (INSM) | 2000 | 45,007.28% |
NeoGenomics (NEO) | 2000 | 2,877.14% |
Manhattan Associates (MANH) | 2000 | 452.23% |
Comstock Resources (CRK) | 2000 | 402.13% |
Labcorp (LH) | 2000 | 377.3% |
Quest Diagnostics (DGX) | 2000 | 360.85% |
Vertex Pharmaceuticals (VRTX) | 2000 | 302.82% |
RadNet (RDNT) | 2000 | 264.71% |
Meritage (MTH) | 2000 | 246.51% |
Pediatrix Medical (MD) | 2000 | 243.75% |
CoreSite Realty (COR) | 2000 | 225.82% |
EOG Resources (EOG) | 2000 | 219.43% |
Everest (EG) | 2000 | 216.03% |
Waters (WAT) | 2000 | 213.62% |
Universal Health Services (UHS) | 2000 | 209.34% |
Encompass Health (EHC) | 2000 | 207.06% |
Sun Life Financial (SLF) | 2000 | 205.34% |
CNX Resources (CNX) | 2000 | 195.06% |
Patterson-UTI Energy (PTEN) | 2000 | 187.92% |
SM Energy (SM) | 2000 | 183.76% |
US Physical Therapy (USPH) | 2000 | 183.58% |
SEI Investments (SEIC) | 2000 | 179.24% |
Ciena (CIEN) | 2000 | 178.37% |
Celldex Therapeutics (CLDX) | 2000 | 175% |
White Mountains Insurance (WTM) | 2000 | 167.66% |